Goldman Sachs
LOXO

Goldman Sachs’s Loxo Oncology, Inc LOXO Stock Holding History

Goldman Sachs’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-75,000
Closed -$8.65M – 6223
2018
Q1 		$8.65M Hold
75,000
– – ﹤0.01% 2463
2017
Q4 		$6.31M Buy
75,000
+28,000
+60% +$2.33M ﹤0.01% 2805
2017
Q3 		$4.33M Hold
47,000
– – ﹤0.01% 3294
2017
Q2 		$3.77M Buy
+47,000
New +$2.6M ﹤0.01% 3296

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Goldman Sachs's LOXO Position: Q1 2019 in Review

Goldman Sachs sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 232,815 shares — an estimated $32.6M sold.

Goldman Sachs first reported a position in LOXO in Q3 2014 and held it in 12 quarters. The position peaked at $41.2M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • Goldman Sachs reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • Goldman Sachs sold 232,815 Loxo Oncology, Inc shares in Q1 2019, an estimated $32.6M.
  • Goldman Sachs first reported a position in Loxo Oncology, Inc in Q3 2014 and held it in 12 quarters.
  • Goldman Sachs's Loxo Oncology, Inc position peaked at $41.2M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Goldman Sachs's 13F filing for Q1 2019, filed 15 May 2019.